Elizabeth G. Demicco, MD, PhD is a Bone and Soft Tissue Pathologist at Mount Sinai Hospital in Toronto, a Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto, and an internationally recognized expert in sarcoma pathology. Dr. Demicco earned her MD and PhD in Biochemistry at Boston University School of Medicine. She then completed residency in Anatomic Pathology at the Massachusetts General Hospital, followed by fellowships in Selective Pathology (Soft Tissue and Cancer Biomarkers) at The University of Texas MD Anderson Cancer Center. She was a faculty member at Mount Sinai Hospital in New York from 2012-2017, where she served as the director of the Bone and Soft Tissue (2016-2017) and the Head and Neck Pathology Services (2014-2017). She subsequently moved to Toronto to focus exclusively on the diagnosis and molecular biology of mesenchymal tumors. Dr. Demicco has co-authored over 100 original articles, review articles, book chapters in the field of bone and soft tissue pathology, and has lectured internationally at pathology, medical oncology, and multidisciplinary sarcoma conferences. She was awarded the 2018 Junior Scientist Award from the Canadian Association of Pathology, and was a co-recipient of the 2020 Team Science award from the American Association for Cancer Research for her contribution to The Cancer Genome Atlas project. She is actively involved in both local and international collaborative studies in the sarcoma field, including the Clinical Proteomic Tumor Analysis Consortium. However, she is perhaps best known for her work on predicting the behavior of solitary fibrous tumors, and for the risk model that bears her name.